The comparative studies on topical corticosteroids and antihistamins have not always demonstrated a significant difference between them in their therapeutic efficacy. According to the existing evidence, fluticasone propionate that is an aqueous nasal corticosteroid spray, is an effective drug in the treaiment of allergic rhinitis with little side effects. Therefore, this study has been done to compare the therapeutic effect and side effects of the aqueous nasal fluticasone propionate spray with pyrilamin maleate tablet in the treatment of allergic rhinitis. The randomized clinical trial strategy of this study was performed on patients with at least three of the symptoms and signs of allergic rhinitis (rhinorrea, sneezing, nose and throat itching, nasal congestion, snuffle and tearing) who had referred to otolaryngology clinic of Loghman Hakim hospital from October 1999 to April 2000. For this purpose, 60 patients were divided into two groups, the case group was treated with fluticasone propionate, 4 puff (200 μg) daily and the control one with oral pyrilamin maleate 25 mg three times a day for three weeks. Then, they were visited at 2nd, 3rd and 5th weeks (that is, two weeks after drug cessation) and were examined by a resident who was unaware of drug. In each visit, symptoms and signs of allergy and side effects of drugs were assessed. Two groups were matched for age, sex and smoking habit and interfering factors such as septal perforation and obstruction of nose more than 50% were removed from the study. The patients (60) were divided into two groups: case and control. The mean age in case and control groups was 30.6±11.8 and 33.6±11.8 respectively. The case group consisted of 16 male (53.3%) and 14 female (46.7%) and for that of control group, 17 male (56.7%) and 13 female (43.3%). The number of smokers was 2 (7%) in control group and 3 (10%) in case one. Tearing and nasal congestion, were significantly lower in all of the three visits in the case group than the control one (P<0.05). In addition, throat and nasal itching, snuffle and nasal mucosal pallor was lower in the case group only at the time of drug consumption. Rhinorrhea, sneezing, nasal obstruction and clear discharge from nose was significantly lower only at the follow up period (5th week). The only side effect that had significant difference between the 2 groups was sedation in the control group. In the case group, one patient refused to continue therapy because of occurrence of dyspnea and one patient (3.3%) had relatively sever epistaxis and 2 patients (6.6%) had mild epistaxis. These side effects had no significant difference in comparison with control group. It is concluded that aqueous nasal spray off luticasone has better and longer effect in the treatment of tearing and nasal congestion and has longer effect on rhinorrhea, sneezing, nasal obstruction and clear nasal discharge, and better effect on throat and nasal itching, snuffle and mucousal palor only with its consumption. It seems reasonable that aqueous nasal spray of fluticasone has more efficacy than pyrilamin maleate and is with lower side effects in the treatment of allergic rhinitis.